A federal appeals court ruled unanimously Wednesday that an antitrust class action lawsuit, in which two health clinics alleged four [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
The U.S. Department of Health and Human Services (HHS) touted the agency’s recently announced plan to pilot a 340B rebate [...] …
A Washington D.C. federal court this week rejected the Department of Health and Human Services’ (HHS) request to partially dismiss [...] …
President Donald Trump is urging more than a dozen leading pharmaceutical manufacturers to begin implementing his proposed “most-favored nation” (MFN) [...] …
A key Senate Republican and outspoken 340B critic recently argued that any comprehensive efforts to address healthcare affordability in Congress [...] …
A North Carolina-based drugmaker recently tightened its 340B contract pharmacy restrictions to limit distribution of a pulmonary arterial hypertension treatment—just [...] …
340B covered entities and drugmakers offered competing criticisms Thursday of the Health Resources and Services Administration’s (HRSA) newly released 340B [...] …
A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...] …
The dark money group behind a campaign targeting GOP-led states’ recent efforts to enact 340B contract pharmacy access laws released [...] …
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...] …